After months of negotiations, Congress passed a $900 billion COVID-19 relief bill Monday night, sealing the deal at long last on a wide-ranging aid package that includes everything from unemployment benefits to rural broadband.
All members of Kansas congressional delegation voted for the bill, which is the most significant injection of aid dollars since the CARES Act was approved in the spring. It was awaiting President Donald Trump s signature, which was expected later Tuesday.
There were also some significant components not included in the legislation namely direct aid for state and local governments, which many states, Kansas included, have called for to help balance their budgets.
On January 1, 2021, patients will be able to inform their pharmacist if they have less than a week’s supplies of diabetes-related medication or supplies. The pharmacist can issue the drugs or supplies after checking with the state’s emergency drug monitoring program and using their professional judgement. It s unconscionable that anyone should have to limit or go without a common and widely-available life-saving drug on an emergency basis in America in 2021, said State Sen. Slap said in a press release. “The Connecticut legislature stepped in to help resolve this crisis, and our residents will be better for it.”
According to the state public health department, nearly 10%, or about 275,000 Connecticut residents have diabetes, which is the seventh leading cause of death in the state.
URL goes live when the embargo lifts
A national survey of approximately 4,000 adults who live in households with firearms found that fewer than 10 percent have ever discussed firearm safety with a clinician (12% of those with children, 5% of those without). When conversations occurred, the most common advice given across all clinical settings was to lock all household firearms. A brief report is published in
Annals of Internal Medicine.
Researchers from Northeastern, Harvard, and Quinnipiac Universities analyzed data from the 2019 National Firearms Survey, conducted online from July to August 2019. Adults living in homes with firearms were asked if a physician or other health care provider ever spoke to them about firearm safety. If yes, the participants were asked where the discussions occurred and whether the patient was an adult or child. They were also asked about the advice given.
Search jobs Human Insulin Market Size, Share | Global Industry Research on Growth, Trends and Opportunity 2020-2026
Pune, Maharashtra, India, December 18 2020 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Global Human Insulin Market is valued around USD 33597.06 Million in 2018 and expected to reach USD 56984.99 Million by 2025 with the CAGR of 7.84% over the forecast period.
Increasing demand for advanced healthcare technology and rising number of patients affected by diabetes and growing disposable income of people are some factors driving the growth of global human insulin market.
Human Insulin, also mentioned as Regular Insulin, could also be a short-acting kind of insulin used for the treatment of hyperglycemia caused by Type 1 and type 2 Diabetes. Human insulin is produced by recombinant deoxyribonucleic acid technology and is simply like endogenously produced insulin. Characteristically prescribed for the management of DM,
INDIA New England News
Amy Finkelstein (MIT)
CAMBRIDGE, Mass. About 35 percent of women get annual mammograms from age 40 onward. But the value of those screenings has been much debated, because mammograms for people in their 40s catch relatively few cases of breast cancer, generate plenty of false positive results, and produce some cases of unnecessary treatment.
Thus, while some organizations have advocated for testing to start at age 40, in 2009 the U.S. Preventive Services Task Force recommended that women start regular mammogram screening at age 50, not age 40 a major preventative health policy change.
But a new study co-authored by MIT scholars identifies an important challenge in designing such guidelines: Women who start getting mammograms at age 40 may be healthier than the population of 40-year-old women as a whole and they have a lower incidence of breast cancer than those who do not start getting tested at that age.